MICHELLE A FANALE to Communicable Diseases
This is a "connection" page, showing publications MICHELLE A FANALE has written about Communicable Diseases.
Connection Strength
0.113
-
Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity. Br J Haematol. 2016 11; 175(3):531-533.
Score: 0.113